It’s been posted in another thread, but I thought it deserved it own.
The trial showed a statistical significance for Remdesivir improving recovery times, 31% better than control group (p<.001). Mortality rate for the experimental group was 8.0% vs 11.6% for the control, but this difference was not significantly different (p=0.059). That’s not far off .05 so I’ll be interested to see what larger test data reveals.
https://www.niaid.nih.gov/news-even...esivir-accelerates-recovery-advanced-covid-19
If anyone can find a preprint, I’d love to see what the methods are and what the criteria for being admitted to the trial was. I suspect severe cases, but have not seen that confirmed.
The trial showed a statistical significance for Remdesivir improving recovery times, 31% better than control group (p<.001). Mortality rate for the experimental group was 8.0% vs 11.6% for the control, but this difference was not significantly different (p=0.059). That’s not far off .05 so I’ll be interested to see what larger test data reveals.
https://www.niaid.nih.gov/news-even...esivir-accelerates-recovery-advanced-covid-19
If anyone can find a preprint, I’d love to see what the methods are and what the criteria for being admitted to the trial was. I suspect severe cases, but have not seen that confirmed.